- Home
- KO vs NVS Comparison
KO vs NVS Comparison
Compare KO & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KO | NVS |
|---|---|---|
| Founded | 1886 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.8B | 266.5B |
| IPO Year | 1919 | 1991 |
Fundamental Metrics
Financial Performance| Metric | KO | NVS |
|---|---|---|
| Price | $72.58 | $147.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 5 |
| Target Price | $78.83 | ★ $118.00 |
| AVG Volume (30 Days) | ★ 15.7M | 1.4M |
| Earning Date | 02-10-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.80% | 1.76% |
| EPS Growth | ★ 25.34 | N/A |
| EPS | 3.02 | ★ 7.30 |
| Revenue | $47,663,000,000.00 | ★ $56,372,000,000.00 |
| Revenue This Year | $5.66 | $9.38 |
| Revenue Next Year | $5.03 | $2.69 |
| P/E Ratio | $24.13 | ★ $19.56 |
| Revenue Growth | 2.80 | ★ 12.88 |
| 52 Week Low | $61.37 | $97.72 |
| 52 Week High | $74.38 | $148.10 |
Technical Indicators
Market Signals| Indicator | KO | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 63.98 | 71.32 |
| Support Level | $69.79 | $142.82 |
| Resistance Level | $72.24 | $146.35 |
| Average True Range (ATR) | 1.10 | 2.26 |
| MACD | 0.32 | 0.19 |
| Stochastic Oscillator | 97.59 | 95.70 |
Price Performance
Historical ComparisonAbout KO Coca-Cola Company (The)
Founded in 1886, Atlanta-headquartered Coca-Cola is the world's largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.